US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kestra Medical Technologies Inc

19.59

+0.49002.57%

Post-market: 19.590.00000.00%16:53 EDT

Volume:480.71K

Turnover:9.18M

Market Cap:1.14B

PE:-7.10

High:19.88

Open:19.52

Low:17.86

Close:19.10

52wk High:30.00

52wk Low:13.25

Shares:58.35M

Float Shares:30.74M

Volume Ratio:0.55

T/O Rate:1.56%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.7601

EPS(LYR):-5.1308

ROE:-92.65%

ROA:-36.84%

PB:3.97

PE(LYR):-3.82

Loading ...

Overview Company News Filings

Stock Track | Kestra Medical Technologies Soars 5.22% in Pre-Market on Upsized Public Offering Announcement

BRIEF-Kestra Medical Says Co Prices Upsized Primary Public Offering Of 6 Million Shares At $23 Per Share

Kestra:Pricing of Upsized Underwritten Public Offering of 6 Mln Common Shares at a Price to Public of $23.00 per Share

THOMSON REUTERS

BUZZ-Kestra Medical slides on planned share sale

Sector Update: Health Care Stocks Decline Pre-Bell Monday

MT Newswires Live

BRIEF-Kestra Medical Technologies Files For Offering Of 5,500,000 Common Shares - SEC Filing

Kestra Medical Technologies Plans Underwritten Public Offering of 5.5 Million Shares

MT Newswires Live

Kestra Medical Preliminary Fiscal Q2 Operating Loss Widens, Revenue Rises

MT Newswires Live

Kestra Medical Technologies Ltd - Files for Offering of 5,500,000 Common Shares - SEC Filing

THOMSON REUTERS

Kestra Medical Technologies Ltd - Q2 Revenue Expected to Increase 52% to $22.2-$22.6 Mln

THOMSON REUTERS

Press Release: Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results

BTIG Research Initiates Coverage on Kestra Medical Technologies With Buy Rating, $32 Price Target

MT Newswires Live

Kestra Medical Techs Initiated at Buy by BTIG

Kestra Medical initiated with a Buy at BTIG

Kestra Medical Technologies Ltd. Files Initial Beneficial Ownership Statement for Chief Business Officer Timothy P. Moran

Kestra Medical’s ASSURE Wearable Defibrillator Proves Highly Effective and Safe in Largest Real-World Study

Largest Real-World Study of Wearable Defibrillators Confirms Strong Effectiveness and Safety Performance of Kestra’s Assure Device

THOMSON REUTERS

Kestra Medical appoints Timothy Moran as CBO

Press Release: Kestra Appoints Timothy Moran as Chief Business Officer, Strengthening Leadership Team for Next Stage of Growth

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KMTS/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KMTS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KMTS\",,,,,undefined,":{"symbol":"KMTS","market":"US","secType":"STK","nameCN":"Kestra Medical Technologies Inc","latestPrice":19.59,"timestamp":1774296000000,"preClose":19.1,"halted":0,"volume":480708,"hourTrading":{"tag":"盘后","latestPrice":19.59,"preClose":19.59,"latestTime":"16:53 EDT","volume":6920,"amount":135559.63064000002,"timestamp":1774299212729,"change":0,"changeRate":0,"amplitude":0.004084},"delay":0,"changeRate":0.02565445026178002,"floatShares":30737300,"shares":58349053,"eps":-2.7601,"marketStatus":"Post-Mkt","change":0.49,"latestTime":"03-23 18:50:46 EDT","open":19.52,"high":19.88,"low":17.86,"amount":9180508.025411999,"amplitude":0.105759,"askPrice":28.22,"askSize":100,"bidPrice":16.72,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.7601,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774310400000},"marketStatusCode":4,"adr":0,"listingDate":1741237200000,"exchange":"NASDAQ","adjPreClose":19.1,"postHourTrading":{"tag":"盘后","latestPrice":19.59,"preClose":19.59,"latestTime":"16:53 EDT","volume":6920,"amount":135559.63064000002,"timestamp":1774299212729,"change":0,"changeRate":0,"amplitude":0.004084},"volumeRatio":0.552205},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KMTS\",,,,,undefined,":{"symbol":"KMTS","floatShares":30737300,"roa":"-36.84%","roe":"-92.65%","lyrEps":-5.130829,"volumeRatio":0.552205,"shares":58349053,"dividePrice":0,"high":19.88,"amplitude":0.105759,"preClose":19.1,"low":17.86,"week52Low":13.25,"pbRate":"3.97","psRate":"13.65","week52High":29.9999,"institutionHeld":0,"latestPrice":19.59,"eps":-2.7601,"divideRate":0,"volume":480708,"delay":0,"ttmEps":-2.7601,"open":19.52,"prevYearClose":26.52,"prevWeekClose":19.1,"prevMonthClose":23.28,"prevQuarterClose":26.52,"fiveDayClose":19.26,"twentyDayClose":26.69,"sixtyDayClose":27.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KMTS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-17","symbol":"KMTS","fiscalQuarterEnding":"2026/01","expectedEps":-0.6,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1773720000000,"reportTimeType":"post","actualEps":-0.61},{"market":"US","date":"2025-12-11","symbol":"KMTS","fiscalQuarterEnding":"2025/10","expectedEps":-0.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1765429200000,"reportTimeType":"post","actualEps":-0.62},{"market":"US","date":"2025-09-11","symbol":"KMTS","fiscalQuarterEnding":"2025/07","expectedEps":-0.66,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1757563200000,"reportTimeType":"post","actualEps":-0.46},{"market":"US","date":"2025-07-15","symbol":"KMTS","fiscalQuarterEnding":"2025/04","expectedEps":-0.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1752552000000,"reportTimeType":"post","actualEps":-2.09},{"date":"2025-04-14","symbol":"KMTS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":null,"defaultRemindTime":1744660800000,"name":null,"time":"Post Market","dateTimestamp":1744603200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KMTS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KMTS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5714,"buy":0.2857,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":7,"updateTime":1764993600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KMTS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KMTS","date":"2026-03-20","current":-7.097569,"percent":0.874525,"low":-16.18499,"twenty":-14.578157,"median":-12.075851,"eighty":-9.350663,"high":-6.523816,"avg":-11.923625,"sd":2.7296,"marketCap":1141782784},"quantilePoints":[{"date":"2025-03-07","current":-12.35476,"twenty":-12.554885,"median":-11.180499,"eighty":-10.006238,"marketCap":1039714860},{"date":"2025-03-14","current":-12.970055,"twenty":-12.629049,"median":-12.407735,"eighty":-11.210518,"marketCap":1091494957},{"date":"2025-03-21","current":-15.207953,"twenty":-14.317672,"median":-12.666719,"eighty":-12.218204,"marketCap":1279825304},{"date":"2025-03-28","current":-14.287183,"twenty":-14.764032,"median":-14.024977,"eighty":-12.386545,"marketCap":1202337886},{"date":"2025-04-04","current":-14.189618,"twenty":-15.037214,"median":-14.238401,"eighty":-12.435988,"marketCap":1194127299},{"date":"2025-04-11","current":-14.805497,"twenty":-14.959162,"median":-14.287183,"eighty":-12.468949,"marketCap":1245956631},{"date":"2025-04-17","current":-14.968672,"twenty":-14.980528,"median":-14.543291,"eighty":-12.629049,"marketCap":1258042072},{"date":"2025-04-25","current":-14.809821,"twenty":-14.980528,"median":-14.561947,"eighty":-12.901065,"marketCap":1244691421},{"date":"2025-05-02","current":-14.510448,"twenty":-14.980528,"median":-14.57378,"eighty":-13.099329,"marketCap":1219530580},{"date":"2025-05-09","current":-13.853659,"twenty":-14.968672,"median":-14.52687,"eighty":-13.313344,"marketCap":1164330774},{"date":"2025-05-16","current":-15.038934,"twenty":-14.968672,"median":-14.510448,"eighty":-13.429037,"marketCap":1263947167},{"date":"2025-05-23","current":-13.624547,"twenty":-14.968672,"median":-14.499429,"eighty":-13.584223,"marketCap":1145075028},{"date":"2025-05-30","current":-13.862824,"twenty":-14.962867,"median":-14.394364,"eighty":-13.570781,"marketCap":1165101004},{"date":"2025-06-06","current":-12.194886,"twenty":-14.925903,"median":-14.189618,"eighty":-13.303292,"marketCap":1024919173},{"date":"2025-06-13","current":-11.458671,"twenty":-14.858699,"median":-14.070552,"eighty":-12.688615,"marketCap":963044043},{"date":"2025-06-20","current":-9.473031,"twenty":-14.809821,"median":-14.026381,"eighty":-12.478367,"marketCap":796160911},{"date":"2025-06-27","current":-10.936295,"twenty":-14.809821,"median":-13.890825,"eighty":-12.194886,"marketCap":919140942},{"date":"2025-07-03","current":-9.573841,"twenty":-14.806362,"median":-13.853659,"eighty":-11.97616,"marketCap":804633439},{"date":"2025-07-11","current":-9.280577,"twenty":-14.766471,"median":-13.774234,"eighty":-10.800661,"marketCap":779986084},{"date":"2025-07-18","current":-7.426142,"twenty":-14.737973,"median":-13.685643,"eighty":-10.164034,"marketCap":845198877},{"date":"2025-07-25","current":-7.656235,"twenty":-14.706535,"median":-13.590943,"eighty":-9.755909,"marketCap":871386692},{"date":"2025-08-01","current":-7.444188,"twenty":-14.670521,"median":-13.343502,"eighty":-9.553679,"marketCap":847252824},{"date":"2025-08-08","current":-6.654653,"twenty":-14.650201,"median":-12.952105,"eighty":-9.265914,"marketCap":757392676},{"date":"2025-08-15","current":-7.20056,"twenty":-14.646954,"median":-12.647001,"eighty":-8.746062,"marketCap":819524549},{"date":"2025-08-22","current":-7.696839,"twenty":-14.588415,"median":-12.501587,"eighty":-7.538932,"marketCap":876008071},{"date":"2025-08-29","current":-7.990095,"twenty":-14.554847,"median":-12.407735,"eighty":-7.633677,"marketCap":909384697},{"date":"2025-09-05","current":-7.4487,"twenty":-14.54602,"median":-12.194886,"eighty":-7.513667,"marketCap":847766310},{"date":"2025-09-12","current":-8.301398,"twenty":-14.523585,"median":-12.003319,"eighty":-7.534421,"marketCap":944815270},{"date":"2025-09-19","current":-14.584722,"twenty":-14.523585,"median":-12.013371,"eighty":-7.608411,"marketCap":1296516135},{"date":"2025-09-26","current":-13.959662,"twenty":-14.54602,"median":-12.274823,"eighty":-7.65443,"marketCap":1240951158},{"date":"2025-10-03","current":-14.098564,"twenty":-14.523585,"median":-12.454823,"eighty":-7.664356,"marketCap":1253298931},{"date":"2025-10-10","current":-13.595044,"twenty":-14.510448,"median":-12.579795,"eighty":-7.67789,"marketCap":1208538254},{"date":"2025-10-17","current":-13.467717,"twenty":-14.497226,"median":-12.732694,"eighty":-7.691425,"marketCap":1197219463},{"date":"2025-10-24","current":-14.868314,"twenty":-14.54602,"median":-12.952105,"eighty":-7.872793,"marketCap":1321726171},{"date":"2025-10-31","current":-16.18499,"twenty":-14.646954,"median":-13.293239,"eighty":-7.992802,"marketCap":1438772767},{"date":"2025-11-07","current":-15.105605,"twenty":-14.742659,"median":-13.324583,"eighty":-8.032505,"marketCap":1342820283},{"date":"2025-11-14","current":-14.416882,"twenty":-14.807227,"median":-13.467717,"eighty":-8.060477,"marketCap":1281595910},{"date":"2025-11-21","current":-14.463182,"twenty":-14.809821,"median":-13.55734,"eighty":-8.097472,"marketCap":1285711834},{"date":"2025-11-28","current":-15.614912,"twenty":-14.869876,"median":-13.609796,"eighty":-8.15522,"marketCap":1388095449},{"date":"2025-12-05","current":-14.179591,"twenty":-14.886718,"median":-13.624547,"eighty":-8.244551,"marketCap":1260501798},{"date":"2025-12-12","current":-10.996761,"twenty":-14.869876,"median":-13.709795,"eighty":-8.325761,"marketCap":1453474910},{"date":"2025-12-19","current":-11.985631,"twenty":-14.859054,"median":-13.624547,"eighty":-8.369523,"marketCap":1584176788},{"date":"2025-12-26","current":-12.148971,"twenty":-14.838095,"median":-13.55734,"eighty":-8.506631,"marketCap":1605765938},{"date":"2026-01-02","current":-11.707511,"twenty":-14.809821,"median":-13.548744,"eighty":-9.011752,"marketCap":1547416885},{"date":"2026-01-09","current":-11.764901,"twenty":-14.809821,"median":-13.385353,"eighty":-9.109506,"marketCap":1555002262},{"date":"2026-01-16","current":-10.144744,"twenty":-14.805497,"median":-13.305665,"eighty":-9.182822,"marketCap":1340861237},{"date":"2026-01-23","current":-10.908469,"twenty":-14.790929,"median":-13.293239,"eighty":-9.202373,"marketCap":1441805099},{"date":"2026-01-30","current":-10.961444,"twenty":-14.762829,"median":-12.952105,"eighty":-9.265914,"marketCap":1448806985},{"date":"2026-02-06","current":-11.089468,"twenty":-14.737973,"median":-12.732694,"eighty":-9.344283,"marketCap":1465728211},{"date":"2026-02-13","current":-12.122483,"twenty":-14.706535,"median":-12.579795,"eighty":-9.404033,"marketCap":1602264995},{"date":"2026-02-20","current":-11.619219,"twenty":-14.677852,"median":-12.466595,"eighty":-9.422321,"marketCap":1535747074},{"date":"2026-02-27","current":-10.837836,"twenty":-14.653448,"median":-12.365286,"eighty":-9.454702,"marketCap":1432469251},{"date":"2026-03-06","current":-10.462595,"twenty":-14.646954,"median":-12.24477,"eighty":-9.533517,"marketCap":1382872556},{"date":"2026-03-13","current":-8.396564,"twenty":-14.609615,"median":-12.148971,"eighty":-9.533517,"marketCap":1109798988},{"date":"2026-03-20","current":-7.883607,"twenty":-14.578157,"median":-12.075851,"eighty":-9.350663,"marketCap":1141782784}],"updateTime":1774306246374},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KMTS\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1133346453","title":"Stock Track | Kestra Medical Technologies Soars 5.22% in Pre-Market on Upsized Public Offering Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1133346453","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133346453?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:46","pubTimestamp":1764769594,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc (KMTS) saw its stock price surge 5.22% in pre-market trading on Wednesday, following the company's announcement of an upsized public offering.The digital healthcare...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["KMTS"],"gpt_icon":0},{"id":"2588099601","title":"BRIEF-Kestra Medical Says Co Prices Upsized Primary Public Offering Of 6 Million Shares At $23 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2588099601","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588099601?lang=en_us&edition=fundamental","pubTime":"2025-12-03 11:20","pubTimestamp":1764732007,"startTime":"0","endTime":"0","summary":"BRIEF-Kestra Medical Says Co Prices Upsized Primary Public Offering Of 6 Million Shares At $23 Per ShareDec 2 (Reuters) - Kestra Medical Technologies Ltd KMTS.O:KESTRA:PRICING OF UPSIZED UNDERWRITTEN ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nFWN3X813Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2588099802","title":"Kestra:Pricing of Upsized Underwritten Public Offering of 6 Mln Common Shares at a Price to Public of $23.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2588099802","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588099802?lang=en_us&edition=fundamental","pubTime":"2025-12-03 11:13","pubTimestamp":1764731610,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nFWN3X813Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2588377976","title":"BUZZ-Kestra Medical slides on planned share sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2588377976","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588377976?lang=en_us&edition=fundamental","pubTime":"2025-12-01 23:44","pubTimestamp":1764603867,"startTime":"0","endTime":"0","summary":"BUZZ-Kestra Medical slides on planned share sale** Shares of medical device maker Kestra Medical Technologies KMTS.O slide ~10.6% to $24.12** KMTS announces public offering of 5.5 million shares ** BofA Securities, Piper Sandler, J.P. Morgan, Goldman Sachs and Wells Fargo Securities are acting as bookrunners for offering** Capital raise comes just months after KMTS went public in New York following an upsized $202 million IPO** Meanwhile, KMTS expects Q2 2026 revenue between $22.2 million and $22.6 million, compared with $14.7 million a year earlier** Loss from operations expected between $31.6 million and $32 million, compared with $19.1 million a year earlier** KMTS had ~51.3 million outstanding shares as of July 31, per offering prospectus** As of last close, KMTS stock up 58.7% since debut in March  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nL6N3X70SO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","LU0096364046.USD","IE00BSNM7G36.USD","KMTS","LU1069347547.HKD","LU1496350171.SGD","LU1880398471.USD","LU0130102774.USD","LU1496350502.SGD","LU1506573853.SGD","IE00B19Z3581.USD","LU0149725797.USD","LU0345770308.USD","LU0971096721.USD","PIPR","LU0477156953.USD","IE00BLSP4452.SGD","BK4588","LU1074936037.SGD","LU0320765489.SGD","LU2237443382.USD","LU0052756011.USD","LU1280957306.USD","BK4553","LU1868836914.USD","LU2129689514.USD","LU0203347892.USD","LU1804176565.USD","LU2129689605.HKD","LU2237438978.USD","LU0130103400.USD","LU0070302665.USD","IE0004086264.USD","LU1868836591.USD","LU2237443978.SGD","LU2471134796.USD","LU1868837300.USD","BAC","LU0128525689.USD","LU0683600562.USD","IE00BKVL7J92.USD","IE00BFXG1179.USD","LU0251131958.USD","LU0868494617.USD","LU2237443895.HKD","IE00B19Z3B42.SGD","LU2133065610.SGD","BK4559","IE00B1BXHZ80.USD"],"gpt_icon":0},{"id":"2588877372","title":"Sector Update: Health Care Stocks Decline Pre-Bell Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2588877372","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588877372?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:18","pubTimestamp":1764598734,"startTime":"0","endTime":"0","summary":"Health care stocks were declining pre-bell Monday, with the Health Care Select Sector SPDR Fund  0.3% lower and the iShares Biotechnology ETF  down 0.6%.Belite Bio  shares were up more than 11% after the company said a phase 3 trial of Tinlarebant to treat Stargardt disease type 1 met its primary efficacy endpoint.Kestra Medical Technologies  stock was down more than 3% after the company reported a wider preliminary fiscal Q2 operating loss.IDEAYA Biosciences  shares were up more than 5% after the company said it has received clearance from the US Food and Drug Administration for an investigational new drug application to begin a Phase 1 trial of IDE034.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","BLTE","IBB","BK4007","IDYA","BK4139","BK4585","BK4082","BK4588","LABU","XBI","KMTS","XLV"],"gpt_icon":0},{"id":"2588778897","title":"BRIEF-Kestra Medical Technologies Files For Offering Of 5,500,000 Common Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2588778897","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588778897?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:22","pubTimestamp":1764595356,"startTime":"0","endTime":"0","summary":"BRIEF-Kestra Medical Technologies Files For Offering Of 5,500,000 Common Shares - SEC FilingDec 1  - Kestra Medical Technologies Ltd KMTS.O:KESTRA MEDICAL TECHNOLOGIES LTD - FILES FOR OFFERING OF 5,500,000 COMMON SHARES - SEC FILINGSource text: [ID:n0001193125-25-303114]Further company coverage: KMTS.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X70P7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2588720281","title":"Kestra Medical Technologies Plans Underwritten Public Offering of 5.5 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588720281","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588720281?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:15","pubTimestamp":1764594915,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies  said Monday it plans to offer 5.5 million common shares via an underwritten public offering.The company will grant underwriters a 30-day option to purchase up to an additional 825,000 shares at the public offering price, excluding underwriting discounts and commissions, it said.Kestra plans to use the proceeds from the offering to support sales and marketing, ongoing commercialization, research and development, clinical studies, and working capital and general corporate purposes, the company said.BofA Securities, Piper Sandler, JPMorgan, Goldman Sachs, and Wells Fargo Securities are serving as bookrunners for the offering, Kestra said.Kestra shares were down more than 4% in recent Monday pre-bell activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2588672081","title":"Kestra Medical Preliminary Fiscal Q2 Operating Loss Widens, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2588672081","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588672081?lang=en_us&edition=fundamental","pubTime":"2025-12-01 20:59","pubTimestamp":1764593950,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies  reported a preliminary fiscal Q2 operating loss Monday of $31.6 million to $32 million, widening from a loss of $19.1 million a year earlier.Analysts surveyed by FactSet expect a loss of $31.6 million.Revenue for the quarter ended Oct. 31 is expected to be $22.2 million to $22.6 million, up from $14.7 million a year earlier.Analysts polled by FactSet expect revenue of $20.7 million.Shares of the company were up 1.2% in recent Monday premarket activity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2588722572","title":"Kestra Medical Technologies Ltd - Files for Offering of 5,500,000 Common Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2588722572","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588722572?lang=en_us&edition=fundamental","pubTime":"2025-12-01 20:13","pubTimestamp":1764591239,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X70P7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2588724792","title":"Kestra Medical Technologies Ltd - Q2 Revenue Expected to Increase 52% to $22.2-$22.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2588724792","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588724792?lang=en_us&edition=fundamental","pubTime":"2025-12-01 20:01","pubTimestamp":1764590460,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUA4V8WXB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2588083724","title":"Press Release: Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2588083724","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588083724?lang=en_us&edition=fundamental","pubTime":"2025-12-01 20:01","pubTimestamp":1764590460,"startTime":"0","endTime":"0","summary":"KIRKLAND, Wash., Dec. 01, 2025  -- Kestra Medical Technologies, Ltd. , a wearable medical device and digital healthcare company, today reported preliminary financial results for the second quarter fiscal 2026 ended October 31, 2025.\"Revenue is expected to grow by over 50% in the second quarter and continues to exceed our FY26 plan, reflecting sustained commercial momentum as Kestra grows and penetrates the wearable defibrillator market,\" said Brian Webster, President and Chief Executive Officer of Kestra Medical Technologies. \"In addition to our commercial execution, we are encouraged by the meaningful improvement in our gross margin, a result of the attractive unit economics and positive leverage inherent in our business model.\". -- Revenue is expected to be $22.2 to $22.6 million, an increase of 52% at","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2584932167","title":"BTIG Research Initiates Coverage on Kestra Medical Technologies With Buy Rating, $32 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2584932167","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584932167?lang=en_us&edition=fundamental","pubTime":"2025-11-18 20:36","pubTimestamp":1763469369,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies (KMTS) has an average rating of Buy and mean price target of $27.86, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2584931444","title":"Kestra Medical Techs Initiated at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2584931444","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584931444?lang=en_us&edition=fundamental","pubTime":"2025-11-18 19:45","pubTimestamp":1763466300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KMTS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 18, 2025 06:45 ET (11:45 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2584936237","title":"Kestra Medical initiated with a Buy at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2584936237","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584936237?lang=en_us&edition=fundamental","pubTime":"2025-11-18 18:45","pubTimestamp":1763462717,"startTime":"0","endTime":"0","summary":"BTIG initiated coverage of Kestra Medical (KMTS) with a Buy rating and $32 price target The firm says Kestra is “disrupting” the wearable cardiover...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kestra-medical-initiated-with-a-buy-at-btig-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kestra-medical-initiated-with-a-buy-at-btig-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2582479388","title":"Kestra Medical Technologies Ltd. Files Initial Beneficial Ownership Statement for Chief Business Officer Timothy P. Moran","url":"https://stock-news.laohu8.com/highlight/detail?id=2582479388","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582479388?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:29","pubTimestamp":1762810178,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Ltd. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing lists Timothy P. Moran as the beneficial owner, serving in the role of Chief Business Officer. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kestra Medical Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 10, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL3SGQl1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2582870791","title":"Kestra Medical’s ASSURE Wearable Defibrillator Proves Highly Effective and Safe in Largest Real-World Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2582870791","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582870791?lang=en_us&edition=fundamental","pubTime":"2025-11-10 23:09","pubTimestamp":1762787352,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Ltd. has announced primary results from the ASSURE WCD Clinical Evaluation Post-Approval Study , the largest prospective real-world study of wearable defibrillators to date. The results were presented as a late-breaking science session at the American Heart Association  Scientific Sessions 2025 in New Orleans. The study enrolled 21,612 patients across the United States and demonstrated that the ASSURE wearable cardioverter defibrillator  achieved 100% successful conversion for ventricular tachycardia and fibrillation events, meeting its effectiveness endpoint. The device also met its safety endpoint, with an inappropriate-shock rate of 0.0065 per patient-month. Additionally, 94% of patients experienced no false positive shock alarms during wear. Further analyses from the study are expected to be shared at upcoming scientific forums.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL1YYk0w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2582870564","title":"Largest Real-World Study of Wearable Defibrillators Confirms Strong Effectiveness and Safety Performance of Kestra’s Assure Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2582870564","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582870564?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:52","pubTimestamp":1762786320,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nTUA4Q2LTB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2573579939","title":"Kestra Medical appoints Timothy Moran as CBO","url":"https://stock-news.laohu8.com/highlight/detail?id=2573579939","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573579939?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:15","pubTimestamp":1759839326,"startTime":"0","endTime":"0","summary":"Kestra Medical (KMTS) Technologies announced the appointment of Timothy Moran as Chief Business Officer, effective November 3. In this role, Mr. Mo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kestra-medical-appoints-timothy-moran-as-cbo-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kestra-medical-appoints-timothy-moran-as-cbo-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2573952210","title":"Press Release: Kestra Appoints Timothy Moran as Chief Business Officer, Strengthening Leadership Team for Next Stage of Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2573952210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573952210?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:00","pubTimestamp":1759838400,"startTime":"0","endTime":"0","summary":"KIRKLAND, Wash., Oct. 07, 2025  -- Kestra Medical Technologies, Ltd. , a wearable medical device and digital healthcare company, today announced the appointment of Timothy Moran as Chief Business Officer, effective November 3. In this role, Mr. Moran will oversee business strategy, corporate business development, payor engagement and contracting, reimbursement strategy, and revenue cycle management.\"I'm excited to join Kestra at such a pivotal time in the organization's growth,\" said Mr. Moran. \"Kestra's commitment to innovation and patient protection aligns with my passion for building organizations that drive meaningful impact in healthcare. I look forward to working with our payor partners, physicians, and the Kestra team to extend the reach of the ASSURE WCD and the broader Cardiac Recovery System platform so more patients can benefit from proven protection and comprehensive recovery support.\"","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4120","R","BK4232","TISI","SSI","BK4082","KMTS"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}]}}